Keyphrases
Randomized Trial
100%
Aspirin
100%
Acute Coronary Syndrome
100%
Cardiovascular Prevention
100%
High Dose
57%
Glycoprotein IIb/IIIa Inhibitors
28%
Ischemic Events
28%
Ischemia
14%
Receptor Blockade
14%
Inhibition Rate
14%
Low Risk
14%
Steady State
14%
Bleeding
14%
Serum Creatinine
14%
Cardiovascular Events
14%
Secondary Prevention
14%
Odds Ratio
14%
Major Bleeding
14%
Myocardial Infarction
14%
Infarction
14%
Twice Daily
14%
Risk of Death
14%
Reinfarction
14%
Platelet Inhibition
14%
Glycoprotein IIb/IIIa Receptor
14%
Non-fatal
14%
Intention-to-treat
14%
Efficacy Endpoint
14%
Biochemistry, Genetics and Molecular Biology
Low Drug Dose
100%
Drug Megadose
100%
Glycoprotein IIb/IIIa
75%
Receptor Antagonist
50%
Steady State
25%
Creatinine Blood Level
25%
Thrombocyte Aggregation
25%
Receptor Blocking
25%
Pharmacology, Toxicology and Pharmaceutical Science